Aera Therapeutics

About:

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Website: https://aeratx.com

Twitter/X: AeraTx

Top Investors: Google Ventures, Lux Capital, ARCH Venture Partners

Description:

Aera Therapeutics is a biotechnology company that uses its proprietary protein nanoparticle (PNP) delivery platform to help genetic medicines reach their full potential. Aera's platform, which is based on endogenous human proteins, is being developed to address the limitations of current delivery technologies and to extend the reach of genetic medicines to different tissues and applications, thereby benefiting more patients across a broader range of disease areas. In addition, Aera's licensed technology includes a therapeutic enzyme platform based on the discovery of novel, compact, and programmable gene-editing enzymes.

Total Funding Amount:

$193M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

katie(AT)1abmedia.com

Founders:

Feng Zhang, Jason Shepherd

Number of Employees:

101-250

Last Funding Date:

2023-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai